Cargando…
Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
During oncogenesis, tumor cells present specific carbohydrate chains that are new targets for cancer immunotherapy. Whereas these tumor-associated carbohydrates (TACA) can be targeted with antibodies and vaccination approaches, TACA including sialic acid-containing glycans are able to inhibit antica...
Autores principales: | Rodrigues Mantuano, Natalia, Natoli, Marina, Zippelius, Alfred, Läubli, Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537339/ https://www.ncbi.nlm.nih.gov/pubmed/33020245 http://dx.doi.org/10.1136/jitc-2020-001222 |
Ejemplares similares
-
Pembrolizumab-induced optic neuropathy – a case report
por: Daetwyler, Eveline, et al.
Publicado: (2023) -
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade
por: Stanczak, Michal A., et al.
Publicado: (2022) -
Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab
por: Ortega Sanchez, Guacimara, et al.
Publicado: (2018) -
Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
por: Läubli, Heinz, et al.
Publicado: (2015) -
Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in Cancer
por: Wang, Jinyu, et al.
Publicado: (2022)